ブタ大動脈平滑筋に存在する190キロダルトンタンパク質の免疫化学的研究 by YAN  Li-Juan et al.
Immunochemical Characterization of 190K
Protein from Porcine Aorta Smooth Muscle
その他（別言語等）
のタイトル
ブタ大動脈平滑筋に存在する190キロダルトンタン
パク質の免疫化学的研究
著者 YAN  Li-Juan, HATSUKAIWA  Sachiko, HONDA 
Tomoko, YOSHINAGA  Naoki, NIIDA  Naoki,
OKAMOTO  Yoh
journal or
publication title
Memoirs of the Muroran Institute of Technology
volume 53
page range 107-114
year 2003-11
URL http://hdl.handle.net/10258/91
Mem.Muroran Inst. Tech., 53 (2003) 107~114
－ 107 －
Immunochemical Characterization of 190K Protein
from Porcine Aorta Smooth Muscle
Li-Juan YAN*, Sachiko HATSUKAIWA*, Tomoko HONDA*,
Naoki YOSHINAGA*, Naoki NIIDA* and Yoh OKAMOTO＊
(Received 6 May 2003, Accepted 29 August 2003)
Contractility of muscle cell is established by mutual sliding of two types of protein polymers. Myosin
ATPase and actin are the protomers of these filamentous oligomers. Sarcomere is a contractile unit
machinery in striated muscle. However, there is no such unit structure in smooth muscle. During the
studies on unconventional myosin, we have found a 190K actin binding protein from aorta smooth
muscle. This protein has been identified as IQGAP1, an actin binding protein in non-muscle cells. In
order to find out the physiological role of IQGAP1 in smooth muscle, specific antibody has been
prepared. As a first step of the application, the amounts of IQGAP1 in aorta media smooth muscle
has been estimated immunochemically. Further studies on possible IQGAP1 related protein has been
described.
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1  INTRODUCTION
Contractile apparatus of smooth muscle cell appears to
be quite different from those of striated muscle. Even
through there is no sarcomere like motile unit structure
within the smooth muscle, the fundamental mechanism
of smooth muscle contraction is supposed to follow
sliding filament mechanism proposed for striated
muscle. The contractile unit structure and the
mechanism of molecular assembly are not well known
in spite of well documented stabilization of myosin
filament through the light chain phosphorylation in
vitro. Calcium and calmodulin dependent
phosphorylation of myosin light chain activates
actomyosin ATPase resulting in contraction.
However, the contractility and the extents of light chain
phosphorylation is not always to be proportional to the
intra-cellular Ca2+ concentration. (1,2) GTP-dependent
contractility at moderate Ca2+ concentration has been
reported to explain this fact.(3,4) Rho and its effectors  
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dependent process has been proposed for the regulation
of myosin light chain phosphorylation.(5) This
mechanism also appears to be operated in non-muscle
cells for the motility. Particularly, alignment of actin
filament must be essential for the integration of
contractile force. The actin filament in smooth muscle
also appears to exist in less ordered structure such as
dense body.  Filament formation of myosin and actin
and the stability might be much more dynamic nature
than that of striated muscle. The regulatory mechanism
for proper alignment of contractile proteins is not well
known. Another striking property of vascular smooth
muscle is a potential to transform to migratory
synthetic cell type. At this point of view, smooth
muscle cell has properties similar to those of non-
muscle. In fact, myosin Ic, a single headed
unconventional myosin, was identified in aorta smooth
muscle. (6) During the studies on myosin Ic, we have
found another calmodulin related 190kDa protein. This
protein binds to F-actin in an ATP independent manner.
Both the molecular weight and the partial amino acid
sequence indicated a high homology to those of human
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brain IQGAP1, a small GTPase and F-actin binding
protein contributing actin reorganization and cell-cell
adhesion. (7) Immunochemical analysis using anti-
human IQGAP1 antibody also indicated a strong cross-
reactivity with the 190kDa protein. This is a first report
of IQGAP1 exists in muscle cell. We have raised
polyclonal antibody against the aorta IQGAP1 for
further investigation of the physiological roles in
contractile cell in such cases as quantitation,
subcellular localization and screening the binding
partner in the cell. The presence of IQGAP1 in aorta
smooth muscle suggests contributions for cellular
processes such as actin reorganization during
contraction-relaxation cycle, association of cytoskeletal
structure to cell membrane.
2  MATERIALS  AND METHODS
2.1  Chemicals
 Q-Sepharose FF and SP-SepharoseFF ion exchange
resins, Sepharose CL4B resins were purchased from
Amersham Bioscience. ATP were from Roche
Molecular Biochemicals. Anti IQGAP1 antibodies
were purchased from Santa Cruz Biotechnology and
Becton Dickinson Inc. EGTA were purchased from
Sigma. Phenylmethylsulfonyl fluoride (PMSF) and
diisopropyl phosphofluoridate (DFP) were purchased
from Wako Chemical Industry. Other chemicals were
of analytical grade.
2.2  Protein Determination
 Protein concentrations were determined either by
Pierce BCA assay or by biuret method.
2.3  SDS poly acrylamide gel electrophoresis
 SDS-PAGE was carried out according to the method
of Laemmli . (8)
2.4  Proteins
 Rabbit skeletal muscle actin was prepared by the
method of Spudich and Watt.(9) Calmodulin was
prepared from scallop testis according to the method of
Yazawa et al. (10) Calmodulin has been either prepared
from Scallop testis or purchased bovine brain one from
Sigma Chem. Co. Aorta 190kDa protein was prepared
from porcine aorta media smooth muscle following the
procedure for myosin I preparation. (6)
2.5  F-actin Binding Assay  　 
 Binding of F-actin to 190K protein was measured by
co-sedimentation assay as described. (6)
2.6  Antibody Preparation 　
 190kDa was emulsified with Freund's complete
adjuvant (1:1, vol/vol) before immunization. A rabbit
was injected intradermaly with the emulsified
immunogen mixture. For boost immunizations, 1mg of
the 190K protein that was emulsified with Freund's
incomplete adjuvant was injected three times with four
weeks interval, and the antiserum was collected
regularly after the final immunization.
2.7  ELISA and Immuno Blotting
 Samples were electrophoresed on 12% gel in the
presence of SDS, and transferred to a polyvinylidene
difluoride (PVDF) membrane. After blocking in 10%
(w/v) skim milk, 0.5M NaCl, 20mM Tris-HCl (pH7.4),
and 0.05% Tween20 (Solution B) at 4℃ overnight, the
PVDF membrane was incubated with anti-190K
protein antibody that was diluted in solution B
containing 1% bovine serum albumin at room
temperature for 2 hour. Binding of the primary
antibody was detected with horseradish peroxidase
conjugated anti-rabbit IgG. Color development was
done with 2,4-dichloro-1-naphtol and N,N-dimethyl-p-
phenylendiamine sulfate. ELISA, enzyme linked
immunosorbent assay, was done as has been described .
3  RESULTS  AND DISCUSSION
3.1  Isolation of 190K from porcine aorta smooth
muscle
 The 190K protein has been recognized as co-purified
protein with myosin I,  an unconventional myosin, a
single headed molecular motor  with membrane
binding short tail. We developed a procedure to purify
190K protein for the characterization in order to find
out the physiolgical role in smooth muscle cell. It has
been achieved by sequential chromatography of cation
exchange, size exclusion, and anion exchange resins.
Initially, the high salt extract in 1mM EGTA, 1mM
MgCl2, 5% sucrose, 1mM ATP, 20mM Tris Cl (pH 7.5),
0.1mM PMSF, 0.1 mM DFP from minced aorta has
been mixed with SP-Sepharose resin in order to adsorb
190K protein following enrichment by high salt elution.
The crude 190K protein fraction has been separated by
size exclusion chromatography (Sepharose CL 4B).
The pooled fraction confirming 190K protein then been
diluted to decrease the ionic strength for further anion
exchange chromatography. The 190K protein could be
enriched and purified at the Q-Sepharose anion
exchange chromatography during shallow salt gradient
elution. The 190K protein has been eluted at ~ 0.25 M
NaCl during the gradient elution from 0.2 to 0.45M
NaCl. The 190K protein could be separated from
myosin I at this step as shown in Fig.1.
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  190K
  Myosin Ia
Fig.1  Q-Sepharose column chromatography
of aorta 190K protein
A linear salt gradient was developed as described
in “MATERIALS and METHODS”.
Fractions: 5~7, 190K protein; 9~11, myosin Ia
190K protein was eluted at ~0.25M NaCl
                                                                                          
3.2  Binding of 190K protein to F-actin
  As a first step to elucidate the role of 190K protein
for smooth muscle contractility, F-actin has been added
to 190K protein to test their binding, the 190K protein
alone could not be spun down under the centrifugal
condition for F-actin pelletting at the bottom as shown
in Fig.2. In the presence of F-actin, most of 190K
protein was found in the precipitate after ultra
centrifugation. This shows the binding of 190K protein
to F-actin. Furthermore, the binding could also be
observed in the presence of Mg ATP. It is therefore,
aorta 190K protein appears to be a F-actin binding
protein but not to be a family of myosin molecular
motor
  STD   A   C   M    S    P
 
Fig. 2  F-actin binding of aorta 190K protein
A, rabbit skeletal F-actin; C, Q-Sepharose purified
190K protein;M, mixture of  A and C; S and P,
supernatant and precipitate after centrifugation of
M, respectively.
         Fraction number
STD      3    5     7    9    11    13
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3.3 Identification of aorta 190K protein as IQGAP
1.
  To identify the F-actin binding 190K protein found
in aorta smooth muscle, we have examined the internal
amino acid sequence of 190K protein. In order to
achieve higher quality of sequence data, the 190K
protein  was extracted from  gel after SDS-PAGE of
column purified 190K fraction. This was effectively
done using pre-labelling of 190K protein with  a thiol
directed fluorescent probe following extraction of
fluorescent 190K protein without fixative staining, as
shown in Fig.4. The extracted 190K protein has been
cleaved proteolytically and seperated  in SDS-PAGE.
The fragments were blotted on to PVDF membrane and
were sequenced. We found a exact match of these
sequence with that of IQGAP1 using BLAST on the
web as shown in Fig. 3.
　　207　　　　　　　　　　226
　　ANELSVDEAALHAAVIAINE
Ｎ　　　　　　　　　　　　　　　 Ｃ
1                            1657
Fig. 3  Partial amino acid sequence of aorta 190K
protein exists in human brain IQGAP1
                                          
3.4  Calmodulin binding to aorta 190K protein.
 IQGAP 1 has been known as a calmodulin binding
protein as well as a microfilament binding property.
In order to test the properties of 190K protein as
IQGAP1, binding of 190K protein to calmodulin-
Sepharose resin in the presence or absence of calcium
ion has been confirmed. (data not shown)
3.5  Rasing antibody against aorta IQGAP 1 and
its utilization for the quantitation in aorta smooth
muscle
 It is keen to detect and quantitate aorta IQGAP1 for
finding the biological function. Polyclonal antibody
has been raised in rabbit by intradermal injection of
aorta IQGAP1. The antigen has been extracted from
SDS-PAGE gel without fixative CBB staining. For this
propose, aorta IQGAP 1 soon after Q-Sepharose
purification was fluorescently labeled prior to SDS
PAGE. The fluorescent band of aorta IQGAP1 has
been cut out and extract IQGAP1 with PBS overnight
at 4℃ for four times as shown in Fig.4. The overall
recovery of IQGAP1 from SDSPAGE gel was ~80%.   
(A) (B)
    CBB     before Staining
 Std   C   E     Std   C  E
Fig. 4  Extraction of  fluorescent aorta IQGAP1 from SDSPAGE
(A) Crude IQGAP1 as C; Extracted IQGAP1 as E; (B) time course
of  extraction, ②as C in (A), ③～⑥　for 1st～4 th day extracts.
Purified and SDS denatured IQGAP1 was emulsified
with adjuvant (1:1,vol/vol) before immunization. A
rabbit was injected at each hind quadricep, and
additionally over both shoulders for three times every 4
weeks. Rabbit serum has been taken before in between
and after these injections and were examined the
antibody production by both enzyme linked immuno
adsorbent assay (ELISA) and western blotting as
shown in Fig.5 and 7. Immunization using native 190K
following conventional method was unsuccessful. (data
not shown)
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Fig. 5 Time cource of anti-aorta IQGAP1 antibody production during immunization
(A) ELISA at each immnization periods (weeks), ○(0), ●(4), □(6), ■(8), △(10), ▲(12);
(B) Time course of specific antibody production
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Fig. 6  Anti-aorta IQGAP1  recognize
equally both native(▲) and SDS denatured(●)
IQGAP1.
The anti IQGAP1 antibody can be used for the antigen
determination at 4000fold dilution. The antibody
recognize aorta IQGAP1 equally at both native and
denatured conformations as shown in Fig.6.
3.6  Immunochemical characterization of IQGAP1
in aorta smooth muscle.
 As a first step for finding physiological function of
IQGAP1 in aorta smooth muscle, the amounts in tissue
has been determined using calibrated immuno blotting.
Calibration curve has been made using highest purify
of aorta IQGAP1 as has been prepared acording to the
method described in previous section. A set of
densitogram was taken using known amounts of
IQGAP1 as shown in Fig.7.   
A linear correlation between the amount of IQGAP1
and the integrated peak area enable us to determine the
amount of IQGAP1 present in aorta tissue as ~1.5 mg
in 250g of tissue. Furthermore, we have found another
90kDa protein recognized by anti IQGAP1 antibody.
This 90kDa protein, however, did not co-purified with
190K IQGAP1 as shown in Fig.8.
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　　　　　　　　　　　　　　　　　　　CBB　    Fold of antibody dilution
　(A)　　　　　　　　　　　　　　　　　(B)　STD IQGAP1 x100  x250  x1000  x4000
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0 0.5 1 1.5 2 2.5
Blotted IQGAP1(μg)
In
te
gr
at
ed
 D
en
si
ty
 (
ar
bi
tr
ar
y 
un
it
)
     
Fig.7 Quantitation of aorta IQGAP1 at micro gram quantities
(A) Densitograms of IQGAP1 immunoblot are proportional to the amounts of protein applied.
(B) Sensitivity of immuno detection determined by serial dilution of antibody on western blot
 CBB           Immuno blot
 STD     IQGAP1    A     B     C      D
Fig.8 Quantitation of IQGAP1 in aorta media smooth muscle
and a indication of IQGAP1 related 90kDa protein
A, SP-Sepharose fraction; B and C, 55% ammonium sulfate supernatant
and precipitate, respectively; D, Sepharose 4BCL fraction
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 CBB           Immuno blot
 STD       C   S1   P1   M   S2   P2
Fig. 9  IQGAP1 related 90kDa protein is not a F-actin binding protein
C, mixture of IQGAP1 and 90kDa protein; S1 and P1, supernatant
and precipitate after centrifugation of C, respectively; M, C plus
 F-actin,S2 and P2, supernatant and precipitate after centrifugation
 of M, respectively
It is interesting to see if the 90kDa protein bind to F-
actin. This was examined by ultracentrifugation of a
fraction containing both 190K and 90K protein with or
without F-actin. The data clearly showed that 90K
protein could not bind to F-actin as shown in Fig.9.
Therefore, 90K protein appears to have a common
epitope with that of aorta IQGAP1 except F-actin
binding site. It is possible to estimate that the
90Kprotein might be similar to carboxy terminal half
of IQGAP1 since the actin binding domain locate at the
amino terminal end. It is of interesting to see if the 90K
protein contains GAP related domain since similar
protein has been reported.
   Contractile mechanism of smooth muscle seems to
be complex. Intracellular alignment of contractile
protein within smooth muscle cell appears to be
irregular if we compare to see those of striated muscle
cell. There is no sarcomere like regularity in the
positions of myosin or actin. This striking difference
between the two types of muscle cell remind us to
think how smooth muscle contractile apparatus has
been made for the integration of molecular power
strokes, even though it might be a temporal structure.
   It is accepted that fundamental mechanisms of
contraction are common for striated and smooth
muscle. In spite of common concept of mutual sliding
between actin and myosin necessary for contraction,
the architectures of the contractile apparatus are
distinct with each type of muscle. In the case of smooth
muscle, there is no sarcomere like unit structure within
the cell.  Moreover, phosphorylation of the myosin
light chain regulates the filament formation upon the
activation by intracellular Ca2+ increase. This calcium
regulatory mechanism is further modulated by GTP
dependent amplification. On the other hand, vascular
smooth muscle cell is known to undergo transformation
the contractile cell type to migratory synthetic one in
the case of endothelial cell damage. This might have
implied an existence of unconventional myosin
necessary for the cell migration as well known in non-
muscle cell motility. As a result for first step to
examine this possibility, we have identified myosin Ic
from porcine aorta smooth muscle.（6） The subcellular
localization in A10 cell have shown a diverse
distribution including some ten percent in the cytosol.
（11） During the course of this study, we have found
another calmodulin related 190K protein.
    In this report, we have shown the purification
method and the binding affinity with calmodulin, F-
actin. The partial amino acid sequence indicates a close
similarity to those of human brain IQGAP1. All of
these data indicate that aorta 190K protein is IQGAP1
identified in muscle for the first time.  It should be
noted that the yield of aorta 190K protein from tissue is
comparable with that reported for that of IQGAP1 from
adrenal gland.（12）At present, the exact function of
IQGAP1 in vascular muscle cell is not known.
Several pioneer works (13-15) about IQGAP1 in non-
muscle cells suggest the functions as a cytoskeletal
reorganizer concerning the migration and cell-cell
adhesion.  It is interesting to see if corresponding
functions exist in vascular smooth muscle cell.
Particularly, contribution of crosslinking actin
filaments by IQGAP1 is attractive possibility involved
in the contraction-relaxation mechanism and its
regulation. Slow tension development and its
maintenance of smooth muscle could be influenced by
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such contribution. In any case, it is keen to clarify the
regulatory mechanism of binding between IQGAP1
and F-actin modulated by cdc42, guanine nucleotides,
calcium and calmodulin. It might be critical
information to find out the physiological significance
of IQGAP1 in vascular smooth muscle cell.
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ブタ大動脈平滑筋に存在する 190キロダルトンタンパク質の免疫化学的研究
厳麗娟*、廿日岩幸子*、本田智子*、吉永直樹*、新井田直樹*、岡本洋*
平滑筋は横紋筋と異なり発生張力の効率的集積を実現する収縮単位構造サルコメアが存在し
ないので、強力な収縮力発生の分子像が描けていない。血管平滑筋細胞は動脈硬化発症に際
し内皮細胞の損傷などを契機として収縮型形質から遊走性合成型形質へと転換する。我々は
細胞遊走性に必要な生体膜結合性ミオシンを探索中にアクチン結合性を示す 190K タンパク
質を見つけた。その一次構造などから筋細胞では存在の知られていなかった IQGAP1 とい
うアクチン細胞骨格の再構築や細胞接着に関与するタンパク質であることが判明した。その
機能解明に必須な特異抗体の調製とその性能、およびこれを用いた血管平滑筋における
IQGAP1 の存在量の推定結果を示した。
キーワード：アクチン結合性、平滑筋、IQGAP1
＊　応用化学科
